HNWAG
BLTE

High Net Worth Advisory Group’s Belite Bio BLTE Stock Holding History

High Net Worth Advisory Group’s Portfolio BLTE Stock Details BLTE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$539K Hold
3,500
– – 0.11% 145
2026
Q1 		$558K Hold
3,500
– – 0.13% 138
2025
Q4 		$560K Hold
3,500
– – 0.13% 131
2025
Q3 		$259K Buy
+3,500
New +$230K 0.06% 203

Other funds holding BLTE

Walleye Capital
Walleye Capital New York $28B AUM 44.22% 1-Year Est. Return
CFM
Capricorn Fund Managers London, United Kingdom $1.27B AUM 70.17% 1-Year Est. Return
DACS
Dymon Asia Capital (Singapore) Singapore $2.39B AUM 150.5% 1-Year Est. Return
GI
GAMMA Investing Foster City, California $2.69B AUM 42.78% 1-Year Est. Return
Mirae Asset Global Investments
Mirae Asset Global Investments Seoul, South Korea $67.7B AUM 51.91% 1-Year Est. Return
EFMH
E Fund Management (HK) Central, Hong Kong $302M AUM 64.42% 1-Year Est. Return
Citigroup
Citigroup New York $303B AUM 53.02% 1-Year Est. Return
SS
SBI Securities Tokyo, Japan $4.4B AUM 74.25% 1-Year Est. Return
WPA
West Paces Advisors Atlanta, Georgia $596M AUM 22.29% 1-Year Est. Return
EWA
EverSource Wealth Advisors Birmingham, Alabama $2.97B AUM 28.74% 1-Year Est. Return

High Net Worth Advisory Group's BLTE Position: Q2 2026 in Review

High Net Worth Advisory Group held its Belite Bio (BLTE) position steady in Q2 2026 at 3,500 shares worth $539K. The position accounts for 0.11% of the portfolio, ranked #145.

High Net Worth Advisory Group first reported a position in BLTE in Q3 2025 and has held it in 4 quarters since. The position peaked at $560K in Q4 2025. 12 funds tracked by Wall St. Rank hold BLTE as of Q2 2026.

  • High Net Worth Advisory Group held 3,500 shares of Belite Bio worth $539K as of Q2 2026.
  • High Net Worth Advisory Group left its Belite Bio share count unchanged in Q2 2026.
  • Belite Bio made up 0.11% of High Net Worth Advisory Group's portfolio in Q2 2026, its #145 holding.
  • High Net Worth Advisory Group first reported a position in Belite Bio in Q3 2025 and has held it in 4 quarters since.
  • High Net Worth Advisory Group's Belite Bio position peaked at $560K in Q4 2025.
  • 12 funds tracked by Wall St. Rank held Belite Bio as of Q2 2026.

Based on High Net Worth Advisory Group's 13F filing for Q2 2026, filed 29 Jul 2026.